Prescient Therapeutics Ltd (PTX) — Cash Flow Reinvestment Rate

Latest as of June 2013: 0.00x

Prescient Therapeutics Ltd (PTX) has a Cash Flow Reinvestment Rate of 0.00x as of June 2013, reinvesting AU$0.00 (capex AU$0.00 ) from operating cash flow of AU$32.65K. See cash generation quality of Prescient Therapeutics Ltd to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

AU$0.00

Capex + Investments

Operating Cash Flow

AU$32.65K

AUD

Capital Expenditures

AU$0.00

AUD

Prescient Therapeutics Ltd Cash Flow Reinvestment Rate (1991–1993)

Historical reinvestment intensity for Prescient Therapeutics Ltd across 2 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Prescient Therapeutics Ltd.

Annual Cash Flow Reinvestment Rate for Prescient Therapeutics Ltd (1991–1993)

Year-by-year capital reinvestment analysis for Prescient Therapeutics Ltd. See financial agility of Prescient Therapeutics Ltd to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
1993	0.32x	AU$562.00K	AU$1.74 Million	AU$562.00K	▼ -12.3%
1991	0.37x	AU$269.00K	AU$730.00K	AU$269.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow